Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • abbreviated new drug...

    Tag: abbreviated new drug applications

    You Searched For "abbreviated new drug applications"
    Cadila Healthcare arm gets USFDA nod to market Ranitidine injection

    Cadila Healthcare arm gets USFDA nod to market Ranitidine injection

    Medical Dialogues Bureau12 Dec 2018 10:00 AM IST
    NEW DELHI: Drug firm Cadila Healthcare on Tuesday said its subsidiary has received approval from the US health regulator to market Ranitidine...
    Zydus Cadila gets USFDA nod for skin ointment, stomach ailment drug

    Zydus Cadila gets USFDA nod for skin ointment, stomach ailment drug

    Ruby Khatun Khatun28 May 2018 10:30 AM IST
    New Delhi: Zydus Cadila has received final approval from the US health regulator to market Nystatin ointment and Omeprazole and Sodium Bicarbonate...
    Zydus gets USFDA nod for schizophrenia drug

    Zydus gets USFDA nod for schizophrenia drug

    Ruby Khatun Khatun11 Dec 2017 11:00 AM IST
    New Delhi: Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market Clozapine tablets, used in the treatment...
    Zydus gets USFDA nod for seizure, migraine drug

    Zydus gets USFDA nod for seizure, migraine drug

    Ruby Khatun Khatun28 Nov 2017 1:53 PM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Topiramate extended-release capsules,...
    Zydus Cadila gets USFDA nod to sell erectile dysfunction drug

    Zydus Cadila gets USFDA nod to sell erectile dysfunction drug

    Ruby Khatun Khatun24 Nov 2017 11:05 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Tadalafil tablets, used for the treatment of...
    Ajanta Pharma launches generic ADHD treatment drug in US

    Ajanta Pharma launches generic ADHD treatment drug in US

    Ruby Khatun Khatun23 Nov 2017 10:15 AM IST
    New Delhi: Drug firm Ajanta Pharma said it has launched generic Clonidine Hydrochloride extended-release tablets in the American market after...
    Glenmark gets USFDA nod for contraceptive tablets

    Glenmark gets USFDA nod for contraceptive tablets

    Ruby Khatun Khatun22 Nov 2017 10:30 AM IST
    New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Loestrin tablets used to...
    Zydus Cadila gets USFDA nod for swelling reducing drug

    Zydus Cadila gets USFDA nod for swelling reducing drug

    Ruby Khatun Khatun20 Nov 2017 10:02 AM IST
    New Delhi: Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling...
    Zydus gets USFDA nod for overactive bladder drug

    Zydus gets USFDA nod for overactive bladder drug

    Ruby Khatun Khatun6 Oct 2017 9:49 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...
    Zydus gets USFDA nod to market anti-diuretic nasal spray

    Zydus gets USFDA nod to market anti-diuretic nasal spray

    Ruby Khatun Khatun5 Oct 2017 10:17 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
    Glenmark gets USFDA nod for chest pain tablets

    Glenmark gets USFDA nod for chest pain tablets

    Ruby Khatun Khatun22 Sept 2017 10:47 AM IST
    New Delhi: Glenmark Pharmaceuticals on Wednesday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets used...
    Glenmark looks to file up to 25 product applications annually

    Glenmark looks to file up to 25 product applications annually

    Ruby Khatun Khatun19 Sept 2017 10:19 AM IST
    New Delhi: Glenmark Pharmaceuticals plans to file close to 25 product applications annually over the next five years, the company's chairman has...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok